Harmony Biosciences Holdings (HRMY) Times Interest Earned (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Times Interest Earned of $11.22 for Q1 2026, up 4.22% sequentially from $10.76 in Q4 2025, and up 256.7% YoY from $3.15 in Q1 2025.
Harmony Biosciences Holdings (HRMY) Times Interest Earned (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Times Interest Earned for 8 years, with the latest figure at $11.22 in Q1 2026.
- Quarterly Times Interest Earned rose 256.7% year-over-year to $11.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.86 (down 9.59% YoY) and the FY2025 annual result came in at $4.01, down 7.99% from the prior year.
- Times Interest Earned rose to $11.22 in Q1 2026 per HRMY's latest filing, from $10.76 in the prior quarter.
- Over five years, Times Interest Earned peaked at $13.24 in Q4 2024 and troughed at $0.5 in Q3 2022.
- A 5-year average of $4.01 and a median of $2.18 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2023 and 2024: Times Interest Earned jumped 442.05% in 2023, then slumped 68.66% in 2024.
- Over 5 years, Times Interest Earned stood at $6.38 in 2022, then dropped by 22.28% to $4.96 in 2023, then soared by 166.93% to $13.24 in 2024, then declined by 18.7% to $10.76 in 2025, then climbed by 4.22% to $11.22 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $11.22, $10.76, and $3.66 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 1.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 |
| Mar 31, 2026 | 11.22 |
| Dec 31, 2025 | 10.76 |
| Sep 30, 2025 | 3.66 |
| Jun 30, 2025 | 1.62 |
| Mar 31, 2025 | 3.15 |
| Dec 31, 2024 | 13.24 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 2.18 |
| Dec 31, 2023 | 4.96 |
| Sep 30, 2023 | 2.71 |
| Jun 30, 2023 | 1.97 |
| Mar 31, 2023 | 1.70 |
| Dec 31, 2022 | 6.38 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 1.39 |
| Mar 31, 2022 | 1.16 |
| Dec 31, 2021 | 7.47 |
| Sep 30, 2021 | 1.13 |